PDE5A and erectile dysfunction: For decades, sildenafil, vardenafil, and tadalafil have been used to treat erectile dysfunction through the selective inhibition of cGMP-specific phosphodiesterase type 5 (PDE-5), which is responsible for cGMP degradation in the corpus cavernosum.